Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gen-Probe on track to commercialise WNV (West Nile virus) test:

This article was originally published in Clinica

Executive Summary

Gen-Probe says that it remains on track to file a US marketing application to commercialise its West Nile virus (WNV) blood screening assay in the first quarter of 2005. The San Diego, California firm has begun a pivotal clinical trial of the nucleic acid test, Procleix, WNV, which, since July 2003 has been used to screen the US blood supply for the virus under an investigational new drug application. The assay has been developed in collaboration with Emeryville, California-based Chiron, the test's distributor.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts